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ABSTRACT 
Motivation: A balanced maternal diet during pregnancy is crucial for the proper development of the embryo. In this project, we 
will study the impact of maternal dietary supplementation in the prevention of the development of neonatal strokes and neural 
tube defects (NTDs) using two mouse models.  
1. Neonatal stroke is a pathology with a heterogeneous etiology, leading to important sequelae. Currently, hypothermia is the 
only clinical intervention used in full-term newborns with perinatal asphyxia. However, the influence of diet has recently begun 
to be considered relevant in reducing brain damage in possible future injuries. Thus, maternal diet supplementation with omega-
3 fatty acids as a tool for neuroprotection has been proposed. In order to test this, we will start with the development of a neonatal 
mouse model of hypoxia-ischemia (HI) and characterize the type and severity of brain injury.  
2. Neurulation refers to the neural tube formation process. When neural tube fails to close completely, NTDs are originated, 
including craniorachischisis or spina bifida. While 70% of NTDs can be prevented with folic acid supplementation during 
pregnancy, the rest remains resistant. Loop-tail mouse is a folic acid resistant model of NTDs who carries a mutation for the 
Vangl2 gene (which is involved in the Wnt-PCP pathway). Previous studies have shown that inositol prevents NTDs in folate-
resistant models. Preliminary studies of our group have suggested that maternal supplementation with D-chiro-inositol during 
embryonic days (E)8.5-E10.5 has a positive effect on the dorsal fusion of the neural folds and on the distribution of actin present 
in these. Therefore, we propose to extend the period of supplementation (E1.5-E11.5) to determine whether such effect is more 
pronounced. 
Methods: We used the Rice-Vannucci model of HI modified to postnatal day (P)8 CD1 mice. Pups were subjected to unilateral 
left carotid artery ligation and subsequently exposed to 9% O2 for 45’. Infarct size measurement was done 24h post HI, evaluation 
of brain damage was done 3 days post-HI and behavioural outcomes were assessed at P8, P9 and P12. To assess the impact 
of maternal dietary supplementation in the prevention of NTD we provided water supplemeted with D-chiro-inositol to pregnant 
mice Vangl2+/Lp from E1.5 to E11.5. Embryos were obtained and genotyped at E12.5 for later phenotype analysis. In addition, 
in situ hybridization studies and fluorescent phalloidin stainings were performed 
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